Company profile
UK company 01691369, incorporated on 14 January 1983.
Deltex Medical - Fluid Management - Doppler Cardiac Output Monitoring
Leading fluid management and cardiac output monitoring systems. A single platform, TrueVue with ODM+, measuring flow and pressure directly.
Company number 01691369
Updated 07 Jul 2026 09:49
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AA | Transaction MzUyOTQ3Nzk5MGFkaXF6a2N4
Published 30 Jun 2026 14:03
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Apr 2022 to 30 Sep 2023
Deltex Medical has been awarded an Innovate UK Smart Award to complete the development of SupraQ-PW. SupraQ-PW is an innovative hand-held non-invasive device for the assessment of cardiac function and fluid status for all hospitalised patients. Clinicians currently lack a simple, reliable, non-invasive haemodynamic monitor that rapidly and accurately asse...
1 Jan 2022 to 31 Mar 2022
SupraQ is a non-invasive Cardiac Output (CO) device using Continuous Wave ultrasound. Our technology utilises an ultrasound transducer presented to the suprasternal notch (V-shaped notch at base of neck) to measure blood flow in the ascending aorta. This need has enormous market potential helping over 16 million patients each year. Clinicians currently la...
1 Jun 2020 to 30 Nov 2020
no public description
1 Oct 2019 to 31 Mar 2021
Deltex Medical has been awarded an Innovate UK Smart Award to develop TrueVue - a disruptive technology for the diagnosis and management of the haemodynamics of surgical and critical care patients. It is designed for all patients from new-born to adult, anaesthetised or awake, across all hospital settings. Medicine today faces increasingly complex cases a...
1 Sep 2019 to 31 May 2021
"Deltex is pleased to announce that it has gained Innovate UK funding through a successful bid to the Analysis for innovators round 4: mini projects phase 2 competition. This Innovate UK funding brings with it the opportunity to collaborate with world-class UK agencies to seek solutions to improve existing technologies. Deltex Medical is pleased to be par...
1 Apr 2019 to 30 Jun 2019
"Deltex are pleased to announce that it has gained Innovate UK funding through a successful bid to the Analysis for innovators round 3: mini projects phase 2 competition. This Innovate UK funding brings with it the opportunity to collaborate with world-class UK agencies to seek solutions to improve existing technologies. Deltex Medical is pleased to be pa...
1 Jan 2019 to 31 Mar 2019
"Deltex are pleased to announce that it has gained Innovate UK funding through a successful bid to the Design foundations round 1 2018 competition. Deltex is the world leader in Oesophageal Doppler ultrasound for haemodynamic monitoring. Use of the company's TrueVue Doppler, is proven to reduce the complications suffered by patients after surgery and is r...
1 Jan 2019 to 31 Mar 2019
"Deltex are pleased to announce that it has gained Innovate UK funding through a successful bid to the Analysis for innovators round 3: mini projects phase 2 competition. This Innovate UK funding brings with it the opportunity to collaborate with world-class UK agencies to seek solutions to improve existing technologies. Deltex Medical is pleased to be pa...
1 Jun 2015 to 28 Feb 2017
The accurate measurement of Cardiac Output (CO), the volume of blood pumped/min, is critical for clinicians to assess cardiovascular function & fluid status. Several invasive & non invasive techniques are currently available to determine CO; however these possess limitations with accuracy & suitability for use in all patient types. Deltex Medical (Deltex)...
